Concepedia

Publication | Open Access

MDR1-expressing CD4<sup>+</sup> T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response

DOIFull Paper Access

10

Citations

41

References

2023

Year

Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Céline Rodriguez, Yenkel Grinberg‐Bleyer, Guilhem Lalle, Lyvia Moudombi, Raphaël Schneider, Cyril Dégletagne,
Journal for ImmunoTherapy of Cancer

Abstract

MDR1 favored the enrichment of Th1.17 and Th17 in blood and tumor after NAC that correlated to clinical response.

References

YearCitations

Page 1